Summary of clinical results
A-DERMA
Tolerance and efficacy study of CYTELIUM drying spray under dermatological control in children and infants with non-severe, uncomplicated chickenpox
Population
22 subjects aged 9 months to 13 years:
- Phototype III to V
- With uncomplicated, non-severe chickenpox
Application of CYTELIUM drying spray
2 to 3 applications per day on the treated hemicircle for 15 days
Evaluation criteria
- Physical signs score: erythema, vesicles and papules (scale from 0 to 10)
- Scoring of functional signs: pruritus, pain, crying, insomnia and irritability (scale from 0 to 10)
- Sensations of discomfort (scale from 0 to 10)
- Skin tolerance
Investigatorresults
- After 8 days of use :
95.5% of subjects with good to very good reparative1 and drying efficacy
- After 15 days of use:
0 skin reactions
Excellent tolerance
1 Superficial skin layers
Conclusion
The application of CYTELIUM drying spray is of excellent value in the management of non-severe, uncomplicated chickenpox in infants and children, notably because of its soothing properties on itching and discomfort.
Infography Cytelium varicelle
.PDF 0.43 Mo
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.